Search company, investor...

XERECEPT

Investors Count

Deal Terms

Funding, Valuation & Revenue

1 Fundings

XERECEPT's latest funding round was a Acquired for on November 21, 2005.

XERECEPT's latest post-money valuation is from November 2005.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
11/21/2005	Acquired		Celtic Pharma	$99M	0 FY undefined

Date	11/21/2005
Round	Acquired
Amount
Investors	Celtic Pharma
Valuation	$99M
Revenue	0 FY undefined
Sources

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

XERECEPT Deal Terms

1 Deal Term

XERECEPT's deal structure is available for 1 funding round, including their Acquired from November 21, 2005.

Round	Acquired
Funding Date	$99M
Pre-Money Valuation
Post-Money Valuation	$99M
Amount Raised
Shares Authorized
Issuance Price
Dividend Rate
Liquidation Preferences
Liquidation Price
Participation
Conversion Price
Anti Dilution
General Voting	$99M
Board Voting	$99M
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Acquired	$99M		$99M										$99M	$99M

XERECEPT Investors

1 Investors

XERECEPT has 1 investors. Celtic Pharma invested in XERECEPT's Acquired funding round.

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
11/21/2005	11/21/2005	Celtic Pharma	1 Acquired		Private Equity	Bermuda

First funding	11/21/2005
Last Funding	11/21/2005
Investor	Celtic Pharma
Rounds	1 Acquired
Board Seats
Type	Private Equity
Location	Bermuda